Quest Diagnostics Announces 5% Advance In Q2 Profit

(RTTNews) - Quest Diagnostics (DGX) revealed a profit for its second quarter that gained ground compared to the same period last year.

The company said its bottom line advanced to $178 million, or $1.34 per share. This was higher than $170 million, or $1.25 per share, in last year's second quarter.

Analysts had expected the company to earn $1.32 per share, according figures compiled by Thomson Reuters. Analysts' estimates typically exclude special items.

The company said revenue for the quarter fell 1.0% to $1.91 billion. This was down from $1.93 billion last year.

Quest Diagnostics earnings at a glance:

-Earnings (Q2): $178 Mln. vs. $170 Mln. last year. -Earnings Growth (Y-o-Y): 4.7% -EPS (Q2): $1.34 vs. $1.25 last year. -EPS Growth (Y-o-Y): 7.2% -Analysts Estimate: $1.32 -Revenue (Q2): $1.91 Bln vs. $1.93 Bln last year. -Revenue Change (Y-o-Y): -1.0%

-Guidance: Full year EPS guidance: $5.02 - $5.17 Full year revenue guidance: $7.47 - $7.54 Bln